Venn Health® is a
stand-alone, easy-to-use Excel-based program
which allows you to quickly and reliably query
comorbidity data for the U.S. market. With
access to comprehensive and reliable data,
you're able to gain better knowledge of your
product's market to:
- Establish the value of additional and possibly
related indications
- Understand the magnitude of patients that
may be excluded from therapy
- Create custom patient segmentation in
comorbid diseases/conditions
- Determine diagnosis rates in the general
population
How can Venn Health help you?
By analyzing comorbidity data using Venn
Health, you're able to:
- Eliminate errors – Avoid "double-counting" potential patients in your forecast for products
that can be used to treat more than one
disease or condition.
- Facilitate better drug development
planning – A pharmaceutical product with a
broad range of efficacy may have a marketing
advantage in therapeutic areas with a high
level of disease/condition comorbidity.
- Create more useful forecasts – Provide an
accurate forecast of market potential in both
exclusive and overlapping segments among
a variety of conditions or diseases. Based on
the most recent data, results are projected to
future years for easy import into a forecasting
model.
Venn Health® consists of two modules:
General Health & CNS
Venn Health – General Health
Data is sourced from the National Health
and Nutrition Examination
Survey
31 definable conditions in 8 main categories:
- Cardiology
- Infectious Disease
- Oncology
- Respiratory
- Sleep Disorders
- Urology
- Other Diseases
- Other Measures
Flexible disease definition through:
- Diagnostic threshold limits
- Inclusion or exclusion of diagnosed
and/or treated patients
Venn Health – CNS
Data is sourced from the National
Comorbidity Survey Replication
Covers 23 conditions in 5 main categories,
including:
- Anxiety Disorders
- Mood Disorders
- Impulse Disorder
- Substance Use Disorders
- Eating Disorders
Flexible disease definition through:
- ICD-10-CM or DSM-IV diagnostic criteria
- Timeframe of diagnosis (30 day, 12 month
or lifetime prevalence)
Ready to Learn More about Venn Health?
|